• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

VTT develops piglet vaccination to reduce antibiotics use

Bioengineer by Bioengineer
July 2, 2018
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

VTT Technical Research Centre of Finland has developed a vaccine, diluted into drinking water, to treat diarrhoea on piglets being weaned. The vaccine reduces the global resistance problem caused by excessive antibiotic use.

The vaccine developed by VTT is a new type of product which can replace antimicrobial drugs, such as zinc oxide, used is pig production. Bacterial strains resistant to antibiotics have become a global health threat. Bacteria do not know any boundaries, so this is also a problem for Finland, although Finland uses antibiotics in moderation when treating farm animals.

"The vaccine's production method has proved to be very effective, and it can also be used in the development of other animal vaccines. The method may be available commercially already in the next few years," says Principal Scientist Jussi Joensuu of VTT.

Before that, however, it must be shown in practice that the vaccine is effective and safe. The first animal test was carried out this summer in Belgium, and the results in terms of efficiency are promising.

"When administered in drinking water, the vaccine offers protection exactly where it is needed, namely in the intestine. If the vaccine was injected, most of the antibodies would remain in the bloodstream," says Joensuu.

When still suckling, piglets get enough protection from the sow's milk. The disease emerges when piglets go from liquids to solids, enabling harmful bacteria – usually E. coli – to attach to the intestine. At this stage, the piglet's own antibody production is only starting, and pathogenic bacteria get a foothold in the small intestine leading to diarrhoea. The piglet suffers, its growth slows down and in extreme cases, the diarrhoea causes death. Piglet scour is estimated to cause annual losses of 1-2 billion euros globally.

The vaccine is administered to piglets in drinking water after weaning. The piglet's immune system will recognise the vaccine molecule and start creating antibodies against the bacteria. The antibodies will prevent bacteria from attaching to the receptors in the small intestine, thereby preventing diarrhoea.

Currently porcine post weaning diarrhoea is prevented by means of, for example, diet, hygienic rearing conditions and antibiotics. Globally speaking, up to 70 per cent of antibiotics are used on animals, especially farm animals.

The background for this development lies in Joensuu's dissertation in 2006 in which he proved the effectiveness of the vaccine molecule. At that time the idea was to produce the vaccine molecules in transgenic plants, but the method was not commercially viable.

The expression system chosen by VTT was filamentous fungus Trichoderma reesei. The vaccine is produced by means of fermentation process in a closed bioreactor.

Resistance to antibiotics is a serious health threat. According to the World Health Organization, resistance to antibiotics is a global health threat. This means that antibiotics no longer have the same effectiveness. This increases human and animal illness and mortality and increases health care costs. Resistance to antibiotics has become one of the most serious threats to medicine and veterinary medicine.

###

Further information:

VTT Technical Research Centre of Finland Ltd
Principal Scientist Jussi Joensuu
[email protected], tel. +358 400 657 513

Media Contact

Jussi Joensuu
[email protected]
358-400-657-513
@VTTFinland

http://www.vtt.fi/?lang=en

https://www.vttresearch.com/media/vtt-develops-piglet-vaccination-to-reduce-antibiotics-use

Share12Tweet8Share2ShareShareShare2

Related Posts

Do Your Genes Influence How Lifestyle Choices Affect Aging?

Do Your Genes Influence How Lifestyle Choices Affect Aging?

April 1, 2026
Combining Single-Cell Multiomics Unlocks Precise Identification of Rare Cell Types and States

Combining Single-Cell Multiomics Unlocks Precise Identification of Rare Cell Types and States

March 31, 2026

Genetically Engineered Marmosets Pave the Way for Advancements in Human Deafness Research

March 31, 2026

How Great Hammerhead Sharks Outsmart Ocean Temperature Swings: Insights from FIU Researchers

March 31, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cutting-Edge “Smart” Drugs Revolutionize Cancer Treatment

KIST-IAE Collaborative Team Surpasses Performance Limits in Lithium-Air Batteries with Innovative Two-Dimensional Catalyst

Brain Metastases Show Unique Macrophage Spatial Patterns

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.